David Abramson
Chief, Ophthalmic Oncology Service, Department of Surgery · New York Presbyterian Hospital
Credentials: · · ·
History
PresentOphthalmic Oncology Service Division · New York Presbyterian Hospital
- Present
Ophthalmologic Oncology) Division · New York Presbyterian Hospital
- 1969–1970
Preliminary or Transitional Year
1965–1969
Research
Germline mutations in BAP1 predispose to melanocytic tumors
Nature Genetics · 2011 · 569 citations
Review · Nature Reviews Disease Primers · 2015 · 474 citations
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk
JAMA · 1997 · 457 citations
- JF
191 papers · 14 as a resident
105 papers
81 papers
- PG
66 papers
58 papers
- JC
26 papers
- BM
21 papers
- DF
20 papers · 5 as a resident
Grants
- 2005–2006
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $10.9K · Weill Medical Coll of Cornell Univ
- 1986–2004
- 1986–1995
National Eye Institute · U01
Contact PI · $614.5K · Weill Medical Coll of Cornell Univ
Clinical trials
- 2007–2008
Treatment With Intravitreal Avastin for Large Uveal Melanomas
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
- 2006–2009
Intra-arterial Chemotherapy(Chemosurgery) for Retinoblastoma
Principal investigator · Completed · Phase 1, Phase 2
Weill Medical College of Cornell University